Traumatic Brain Injury
Lancet 356:923-929, Ghajar,J., 2000
Central Nervous System Aspergillosis in Patients with Human Immunodeficiency Virus Infection
Medicine 79:269-280, Mylonakis,E. et al, 2000
Orolingual Angioneurotic Edema Following Therapy of Acute Ischemic Stroke with Alteplase
Neurol 55:599-600, Rudolf,J. et al, 2000
Progressive Multifocal Leukoencephalopathy and Idiopathic CD4+Lymphocytopenia:A Case Report and Review of Reported Cases
Clin Infect Dis 31:E20-22, Haider,S.,et al, 2000
Meningeal Carcinomatosis Manifested as Bilateral Progressive Sensorineural Hearing Loss
Am J Otol 21:510-512, Shen,T.Y., &Young,Y.H., 2000
Association of Primary Central Nervous System Lymphoma with Long-Term Azathioprine Therapy for Myasthenia Gravis?
Ann Neurol 47: 682-683, Herrlinger,U.,et al, 2000
Effect of intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography
Stroke 31:2912-2919, The National Institute of Neurological Disorders a, 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000
MR Imaging of the Cauda Equina in Hereditary Motor Sensory Neuropathies: Correlations with Sural Nerve Biopsy
AJNR 21:1793-1798,1779, Cellerini,M.,et al, 2000
Late Onset Postpartum Eclampsia Without Pre-Eclamptic Prodromi: Clinical and Neuroradiological Presentation in Two Patients
JNNP 69:824-827, Veltkamp,R.,et al, 2000
Contrast-Enhanced MR Angiography of Intracranial Giant Aneurysms
AJNR 21:1900-1907, Jager,H.R.,et al, 2000
Can Emergency Department Physicians Safely and Effectively Initiate Thrombolysis for Acute Ischemic Stroke?
Neurol 55:1801-1805, Akins,P.T.,et al, 2000
Arteriovenous Bubbles Following Cold Water Sport Dives: Relation to Right-to-left Shunting
Neurol 55:1741-1743, Gerriets,T.,et al, 2000
Remedies for HIV-associated Peripheral Neuropathy
Neurol 54:2037-2038, Berger,J.R. &Nath,A., 2000
Adverse Effects of Antiretroviral Therapy
Lancet 356:1423-1430, Carr,A. &Cooper, D.A., 2000
Diffusion-Weighted Magnetic Resonance Imaging in a Case of Methanol Intoxication
Neurotoxicology 21:405-408, Oppenheim, D.S.,et al, 2000
Guillain-Barre Syndrome in a Patient with Non-Hodgkins Lymphoma
Ann Oncol 11:217-220, Schwenk,D.Re.,et al, 2000
Neurosyphilis as a Cause of Facial and Vestibulocochlear Nerve Dysfunction: MR Imaging Features
AJNR 21:1673-1675, Smith, M.M. & Anderson, J.C., 2000
Takayasus Arteritis: Assessment of Disease Activity with Contrast-Enhanced MR Imaging
AJR 175:505-511, Choe, Y.H.,et al, 2000
Effectiveness of Anticholinergics and Neuroleptic Dose Reduction on Neuroleptic-Induced Pleurothotonus (the Pisa Syndrome)
J Clin Psychopharmacol 19:277-280, Suzuki,T.,et al, 1999
Cerebral Venous Thrombosis
The Neurologist 5:326-349, Biousse,V.&Bousser,M., 1999
Polyarteritis Nodosa Presenting as Temporal Arteritis in a 9-Year-Old Child
AJNR 20:167-171, Bert,R.J.,et al, 1999
CT Angiography and Doppler Sonography for Emergency Assessment in Acute Basilar Artery Ischemia
Stroke 30:606-612, Brandt,T.,et al, 1999
Edema Associated with Calcified Lesions in Neurocysticercosis
Neurol 53:777-781, Nash,T.E.&Patronas,N.J., 1999
Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke
Stroke 30:1969-1973, Vaughan,C.J.&Delanty,N., 1999
Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999
Gabapentin-Induced Anorgasmia
Neurol 53:2209, Clark,J.D.&Elliott,J., 1999
Prevalence of Peripheral Neuropathy in Injection Drug Users
Neurol 53:592-597, Berger,A.R.,et al, 1999
The Contribution of Magnetic Resonance Imaging to the Diagnosis of Multiple Sclerosis
Neurol 53:448-456, Fazekas,F.,et al, 1999
Agreement and Variability in the Interpretation of Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy
Stroke 30:1528-1533, Grotta,J.C.,et al, 1999
Evaluation of CSF Leaks:High-Resolution CT Compared with Contrast-Enhanced CT and Radionuclide Cisternography
AJNR 20:706-712, Stone,J.A.,et al, 1999
Evaluation of Early Reperfusion and IV tPA Therapy Using Diffuion- and Perfusion-Weighted MRI
Neurol 52:1792-1798,1733, Marks,M.P.,et al, 1999
Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
NEJM 340:1781-1787, Kwiatkowski,T.G.,et al, 1999
Progression of Mass Effect After Intracerebral Hemorrhage
Stroke 30:1167-1173, Zazulia,A.R.,et al, 1999
Behcet's Disease
NEJM 341:1284-1291, Sakane,T.,et al, 1999
Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999
Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999
MRI Features of Intracerebral Hemorrhage Within 2 Hours from Symptom Onset
Stroke 30:2263-2267, Linfante,I.,et al, 1999
CT and MR Imaging of Neurocysticercosis
AJR 173:1485-1490, Noujaim,S.E.,et al, 1999
The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999
Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999
Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke, Emergency Management of Stroke (EMS) Bridging Trial
Stroke 30:2598-2605, Lewandowski,C.A.,et al, 1999
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999
Is Cholesterol a Risk Factor for Stroke? No
Arch Neurol 56:1521-1524, Landau,W.M., 1999
Is Cholesterol a Risk Factor for Stroke? Yes
Arch Neurol 56:1518-1520,1524, Demchuk,A.M.,et al, 1999
Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999
Wegener Granulomatosis:MR Imaging Findings in Brain and Meninges
Radiology 213:794-799, Murphy,J.M.,et al, 1999
Bell's Palsy and HSV-1 Infection
Muscle & Nerve 22:1476-1478, Marra,C.M., 1999
Highly Active Antiretroviral Therapy Reverses Brain Metabolite Abnormalities in Mild HIV Dementia
Neurol 53:782-789, Chang,L.,et al, 1999
Adult-Onset "Infant" Botulism:An Unusual Cause of Weakness in the Intensive Care Unit
Neurol 53:891, Li,L.Y.J.,et al, 1999